These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9585174

  • 1. Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor binding.
    Raffa RB.
    Life Sci; 1998; 62(16):PL265-70. PubMed ID: 9585174
    [Abstract] [Full Text] [Related]

  • 2. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
    Gobbi M, Moia M, Pirona L, Morizzoni P, Mennini T.
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
    [Abstract] [Full Text] [Related]

  • 3. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX, Venkatanarayanan N, Ho CY.
    J Affect Disord; 2017 Mar 01; 210():211-221. PubMed ID: 28064110
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V.
    CNS Drugs; 2003 Mar 01; 17(8):539-62. PubMed ID: 12775192
    [Abstract] [Full Text] [Related]

  • 5. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.
    Cott JM.
    Pharmacopsychiatry; 1997 Sep 01; 30 Suppl 2():108-12. PubMed ID: 9342770
    [Abstract] [Full Text] [Related]

  • 6. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V, Winterhoff H, Herkenham M.
    Mol Psychiatry; 2001 Sep 01; 6(5):547-64. PubMed ID: 11526469
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus.
    Butterweck V, Böckers T, Korte B, Wittkowski W, Winterhoff H.
    Brain Res; 2002 Mar 15; 930(1-2):21-9. PubMed ID: 11879791
    [Abstract] [Full Text] [Related]

  • 8. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
    Hirano K, Kato Y, Uchida S, Sugimoto Y, Yamada J, Umegaki K, Yamada S.
    J Pharm Pharmacol; 2004 Dec 15; 56(12):1589-95. PubMed ID: 15563766
    [Abstract] [Full Text] [Related]

  • 9. Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
    Fornal CA, Metzler CW, Mirescu C, Stein SK, Jacobs BL.
    Neuropsychopharmacology; 2001 Dec 15; 25(6):858-70. PubMed ID: 11750179
    [Abstract] [Full Text] [Related]

  • 10. St. John's wort: role of active compounds for its mechanism of action and efficacy.
    Butterweck V, Schmidt M.
    Wien Med Wochenschr; 2007 Dec 15; 157(13-14):356-61. PubMed ID: 17704987
    [Abstract] [Full Text] [Related]

  • 11. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE.
    Pharmacol Res; 2003 Feb 15; 47(2):101-9. PubMed ID: 12543057
    [Abstract] [Full Text] [Related]

  • 12. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light.
    Taher MM, Lammering GM, Hershey CM, Valerie KC.
    IUBMB Life; 2002 Dec 15; 54(6):357-64. PubMed ID: 12665247
    [Abstract] [Full Text] [Related]

  • 13. Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study.
    Rahman SZ, Basilakis J, Rahmadi A, Lujic S, Musgrave I, Jorm L, Hay P, Münch G.
    Australas Psychiatry; 2013 Jun 15; 21(3):262-6. PubMed ID: 23439542
    [Abstract] [Full Text] [Related]

  • 14. St. John's wort.
    Med Lett Drugs Ther; 1997 Nov 21; 39(1014):107-8. PubMed ID: 9398822
    [No Abstract] [Full Text] [Related]

  • 15. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J, Anderson LA, Phillipson JD.
    J Pharm Pharmacol; 2001 May 21; 53(5):583-600. PubMed ID: 11370698
    [Abstract] [Full Text] [Related]

  • 16. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R, Koyabu N, Morimoto S, Shoyama Y, Ohtani H, Sawada Y.
    Drug Metab Dispos; 2005 Apr 21; 33(4):547-54. PubMed ID: 15640377
    [Abstract] [Full Text] [Related]

  • 17. St. John's wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces 3-adrenoceptor numbers on cultured rat brain cells.
    Kientsch U, Bürgi S, Ruedeberg C, Probst S, Honegger UE.
    Pharmacopsychiatry; 2001 Jul 21; 34 Suppl 1():S56-60. PubMed ID: 11518078
    [Abstract] [Full Text] [Related]

  • 18. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J, Klejdus B, Kubán V.
    Ceska Slov Farm; 2007 Apr 21; 56(2):62-6. PubMed ID: 17619301
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products.
    Schulte-Löbbert S, Holoubek G, Müller WE, Schubert-Zsilavecz M, Wurglics M.
    J Pharm Pharmacol; 2004 Jun 21; 56(6):813-8. PubMed ID: 15231048
    [Abstract] [Full Text] [Related]

  • 20. Neuropharmacology of St. John's Wort (Hypericum).
    Bennett DA, Phun L, Polk JF, Voglino SA, Zlotnik V, Raffa RB.
    Ann Pharmacother; 1998 Nov 21; 32(11):1201-8. PubMed ID: 9825087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.